Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: European Region
  • Asset Class: Equity
  • Geographic Focus: European Region

BPER International SICAV ₣ 1/64 5/16 Equity Europe Opportunity

+ Add to Watchlist

BISEQEU:LX

124.68 EUR 0.50 0.40%

As of 00:59:30 ET on 05/21/2015.

Snapshot for BPER International SICAV ₣ 1/64 5/16 Equity Europe Opportunity (BISEQEU)

Year To Date: +19.76% 3-Month: +6.99% 3-Year: +18.14% 52-Week Range: 94.96 - 125.75
1-Month: -0.12% 1-Year: +20.17% 5-Year: +10.85% Beta vs LUXXX: 0.79

Mutual Fund Chart for BISEQEU

No chart data available.
  • BISEQEU:LX 124.68
  • 1M
  • 1Y
Interactive BISEQEU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BISEQEU

BPER International SICAV - Equity Europe is an open-end investment fund incorporated in Luxembourg. The Fund aims to invest primarily in stocks of leading European companies which have a powerful market position in their specific area of activity and have a strong capitalization. The Fund will invest primarily in companies located in EU countries that are part of the EMU.

Inception Date: 10-26-1999 Telephone: Not Disclosed
Managers: -
Web Site: -

Fundamentals for BISEQEU

NAV (on 2015-05-21) 124.68
Assets (M) (on 2015-05-21) 36.24
Fund Leveraged N
Minimum Investment 100.00
Minimum Subsequent Investment 100.00

Dividends for BISEQEU

No dividends reported

Fees & Expenses for BISEQEU

Front Load 3.00
Back Load 0.00
Current Mgmt Fee 1.90
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for BISEQEU

Filing Date: 03/31/2015
Name Position Value % of Total
Novartis AG 28,966 2,669,809 7.740%
Bayer AG 9,754 1,365,072 3.957%
Nestle SA 15,242 1,072,458 3.109%
AstraZeneca PLC 15,845 1,013,260 2.938%
Novo Nordisk A/S 20,307 1,011,172 2.931%
Unilever NV 25,288 984,083 2.853%
Sampo Oyj 20,024 941,528 2.730%
Reckitt Benckiser Group PLC 11,182 896,444 2.599%
Aviva PLC 118,657 885,652 2.568%
Pernod Ricard SA 7,323 806,628 2.338%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil